Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Mehta

Showing results (1041-1050 of 1,216) with videos related to

Pageof 122
Sort By:
International Journal of Radiation Oncology, Biology, Physics|November 6, 2017
Investigating the Effect of Reirradiation or Systemic Therapy in Patients With Glioblastoma After Tumor Progression: A Secondary Analysis of NRG Oncology/Radiation Therapy Oncology Group Trial 0525Wenyin Shi, Molly Scannell Bryan, Mark R Gilbert, et al.
Journal of Neuro-Oncology|July 1, 2020
Early imaging marker of progressing glioblastoma: a window of opportunityNa Tosha N Gatson, Shane P Bross, Yazmin Odia, et al.
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists|March 25, 2023
Treatment of glioblastoma using MRIdian® A3i BrainTx™: Imaging and treatment workflow demonstrationAlonso La Rosa, Kathryn E Mittauer, Amy E Rzepczynski, et al.
Plos One|April 23, 2025
Developing a multivariable prediction model to support personalized selection among five major empirically-supported treatments for adult depression. Study protocol of a systematic review and individual participant data network meta-analysisEllen Driessen, Orestis Efthimiou, Frederik J Wienicke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 11, 2010
PF-03732010: a fully human monoclonal antibody against P-cadherin with antitumor and antimetastatic activityCathy C Zhang, Zhengming Yan, Qin Zhang, et al.
Neuro-Oncology Practice|November 15, 2021
Cross-sectional survey of patients, caregivers, and physicians on diagnosis and treatment of brain metastasesAlbert E Kim, Gi-Ming Wang, Kristin A Waite, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 2004
Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: results of a randomized phase III trialChristina A Meyers, Jennifer A Smith, Andrea Bezjak, et al.
Neuro-Oncology|June 19, 2008
Neurooncology clinical trial design for targeted therapies: lessons learned from the North American Brain Tumor ConsortiumSusan M Chang, Kathleen R Lamborn, John G Kuhn, et al.
Journal of Neuro-Oncology|June 5, 2024
Comparative evaluation of outcomes amongst different radiosurgery management paradigms for patients with large brain metastasisTugce Kutuk, Yanjia Zhang, Eyub Yasar Akdemir, et al.
Neurosurgery|April 5, 2018
Influence of Residual Disease Following Surgical Resection in Newly Diagnosed Glioblastoma on Clinical, Neurocognitive, and Patient Reported OutcomesWilliam A Hall, Stephanie L Pugh, Jeffrey S Wefel, et al.
Pageof 122

Showing results (1041-1050 of 1,216) with videos related to

Sort By:
Pageof 122
International Journal of Radiation Oncology, Biology, Physics|November 6, 2017
Investigating the Effect of Reirradiation or Systemic Therapy in Patients With Glioblastoma After Tumor Progression: A Secondary Analysis of NRG Oncology/Radiation Therapy Oncology Group Trial 0525Wenyin Shi, Molly Scannell Bryan, Mark R Gilbert, et al.
Journal of Neuro-Oncology|July 1, 2020
Early imaging marker of progressing glioblastoma: a window of opportunityNa Tosha N Gatson, Shane P Bross, Yazmin Odia, et al.
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists|March 25, 2023
Treatment of glioblastoma using MRIdian® A3i BrainTx™: Imaging and treatment workflow demonstrationAlonso La Rosa, Kathryn E Mittauer, Amy E Rzepczynski, et al.
Plos One|April 23, 2025
Developing a multivariable prediction model to support personalized selection among five major empirically-supported treatments for adult depression. Study protocol of a systematic review and individual participant data network meta-analysisEllen Driessen, Orestis Efthimiou, Frederik J Wienicke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 11, 2010
PF-03732010: a fully human monoclonal antibody against P-cadherin with antitumor and antimetastatic activityCathy C Zhang, Zhengming Yan, Qin Zhang, et al.
Neuro-Oncology Practice|November 15, 2021
Cross-sectional survey of patients, caregivers, and physicians on diagnosis and treatment of brain metastasesAlbert E Kim, Gi-Ming Wang, Kristin A Waite, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 2004
Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: results of a randomized phase III trialChristina A Meyers, Jennifer A Smith, Andrea Bezjak, et al.
Neuro-Oncology|June 19, 2008
Neurooncology clinical trial design for targeted therapies: lessons learned from the North American Brain Tumor ConsortiumSusan M Chang, Kathleen R Lamborn, John G Kuhn, et al.
Journal of Neuro-Oncology|June 5, 2024
Comparative evaluation of outcomes amongst different radiosurgery management paradigms for patients with large brain metastasisTugce Kutuk, Yanjia Zhang, Eyub Yasar Akdemir, et al.
Neurosurgery|April 5, 2018
Influence of Residual Disease Following Surgical Resection in Newly Diagnosed Glioblastoma on Clinical, Neurocognitive, and Patient Reported OutcomesWilliam A Hall, Stephanie L Pugh, Jeffrey S Wefel, et al.
Pageof 122